Stock listing

SLZ0 Stock Price, News, Filings & Events — Enveric Biosciences, Inc.

Selected listing: SLZ0 · MUN · EUR · DE

This page tracks Enveric Biosciences, Inc.'s SLZ0:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SLZ0:MUN. SLZ0:MUN is the stock-level entry point for investors researching Enveric Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Enveric Biosciences, Inc. (Ticker: ENVB) is a public company based in the United States, focusing on the development of innovative therapies. With a market capitalization of approximately $4.75 million, Enveric is dedicated to advancing its research in the biosciences sector. The company aims to address unmet medical needs through its specialized approach.

SLZ0:MUNEURDEUpdated August 31, 2026
Enveric Biosciences, Inc. logo
Ticker
SLZ0:MUN
Asset type
Stock
Market cap
$6.1M
Sector
Health Technology
Industry
Pharmaceuticals: Other
Exchange
MUN
Currency
EUR

Enveric Biosciences, Inc. SLZ0:MUN stock context

This page tracks Enveric Biosciences, Inc.'s SLZ0:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SLZ0:MUN. SLZ0:MUN is the stock-level entry point for investors researching Enveric Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Enveric Biosciences, Inc. (Ticker: ENVB) is a public company based in the United States, focusing on the development of innovative therapies. With a market capitalization of approximately $4.75 million, Enveric is dedicated to advancing its research in the biosciences sector. The company aims to address unmet medical needs through its specialized approach.

Latest news from Enveric Biosciences, Inc.

All Enveric Biosciences, Inc. news →

Research Enveric Biosciences, Inc.

Alternate listings